Juqun Shen

发表

Single Variable Domain-IgG Fusion

Zhen-ping Zhu, Haifan Zhang, X. Jimenez, 2006, Journal of Biological Chemistry.

ratssecretion and sympathetic outflow in Acidic fibroblast growth factor activates

H. Berthoud, P. Bohlen, Y. Oomura, 2013 .

Single variable domain antibody as a versatile building block for the construction of IgG-like bispecific antibodies.

Zhen-ping Zhu, Haifan Zhang, D. Ludwig, 2007, Journal of immunological methods.

Platelet-derived growth factor receptor signaling activates pericyte-myofibroblast transition in obstructive and post-ischemic kidney fibrosis.

J. Duffield, K. Wu, Yung-Ming Chen, 2011, Kidney international.

A bi-functional antibody-receptor domain fusion protein simultaneously targeting IGF-IR and VEGF for degradation

Zhen-ping Zhu, S. Eastman, Haifan Zhang, 2015, mAbs.

Characterization of 7A5: A Human CD137 (4-1BB) Receptor Binding Monoclonal Antibody with Differential Agonist Properties That Promotes Antitumor Immunity

J. Haidar, M. Kalos, Leyi Shen, 2020, Molecular Cancer Therapeutics.

Monoclonal antibody antagonists of hypothalamic FGFR1 cause potent but reversible hypophagia and weight loss in rodents and monkeys.

Peter Bohlen, H. Berthoud, P. Bohlen, 2007, American journal of physiology. Endocrinology and metabolism.

rodents and monkeys cause potent but reversible hypophagia and weight loss in Monoclonal antibody antagonists of hypothalamic FGFR 1

H. Berthoud, P. Bohlen, O. McGuinness, 2007 .

Inhibition of fibroblast growth factor receptor 3-dependent lung adenocarcinoma with a human monoclonal antibody

N. Chehab, D. Ludwig, D. Ornitz, 2016, Disease Models & Mechanisms.

Tailoring in Vitro Selection for a Picomolar Affinity Human Antibody Directed against Vascular Endothelial Growth Factor Receptor 2 for Enhanced Neutralizing Activity*

Peter Bohlen, Dan Lu, P. Bohlen, 2003, Journal of Biological Chemistry.

Development of a fully human anti-PDGFRbeta antibody that suppresses growth of human tumor xenografts and enhances antitumor activity of an anti-VEGFR2 antibody.

Zhen-ping Zhu, Haifan Zhang, D. Ludwig, 2009, Neoplasia.

An antibody directed against PDGF receptor beta enhances the antitumor and the anti-angiogenic activities of an anti-VEGF receptor 2 antibody.

Zhen-ping Zhu, Haifan Zhang, D. Ludwig, 2007, Biochemical and biophysical research communications.

Catumaxomab, a rat/murine hybrid trifunctional bispecific monoclonal antibody for the treatment of cancer.

Zhen-ping Zhu, Juqun Shen, 2008, Current opinion in molecular therapeutics.

Inhibition of fibroblast growth factor receptor 3-dependent lung adenocarcinoma with a human monoclonal antibody

N. Chehab, D. Ludwig, D. Ornitz, 2016, Disease Models & Mechanisms.